Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

In-vitro Effects of Bacterial Melanin in Macrophage “RAW 264.7” Cell Culture

In-vitro Effects of Bacterial Melanin in Macrophage “RAW 264.7” Cell Culture Biotechnologically obtained bacterial melanin (BM) has been extensively studied as a potential pharmacological preparation with neuroprotective and anti-inflammatory effects. Anti-inflammatory action of BM was tested in animal model of induced encephalomyelitis. The goal of presented research was to examine anti-inflammatory potential of BM in lipopolysaccharide-stimulated murine RAW 264.7 cells. The cells were treated with different concentrations of BM (from 6 mg/ml to 4, 2 and 1 mg/ml) and incubated for 20 hours. Results were compared with data obtained from vehicle control treated cells. Two tailed t-test was used to evaluate the results. The obtained data showed that BM reduces the production of nitric oxide and prostaglandin E2. The substance suppresses production of pro-inflammatory cytokines including interleukin (IL)-6 and IL-1b.The results revealed that BM has anti-inflammatory activity and has a potential to suppress neuroinflammation. Brain macrophages-are the only cells that mediate brain inflammation. Extracellular neuromelanin can activate the CNS microglia inducing neuroinflammation and neurodegeneration. The water-soluble biotechnological melanin does not activate microglia – the resident brain macrophages. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Advances in Neuroimmune Biology IOS Press

In-vitro Effects of Bacterial Melanin in Macrophage “RAW 264.7” Cell Culture

Loading next page...
 
/lp/ios-press/in-vitro-effects-of-bacterial-melanin-in-macrophage-raw-264-7-cell-5yCS9gdb96

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
IOS Press
Copyright
Copyright © 2019 © 2019 – IOS Press and the authors. All rights reserved
ISSN
1878-948X
eISSN
1878-9498
DOI
10.3233/NIB-190162
Publisher site
See Article on Publisher Site

Abstract

Biotechnologically obtained bacterial melanin (BM) has been extensively studied as a potential pharmacological preparation with neuroprotective and anti-inflammatory effects. Anti-inflammatory action of BM was tested in animal model of induced encephalomyelitis. The goal of presented research was to examine anti-inflammatory potential of BM in lipopolysaccharide-stimulated murine RAW 264.7 cells. The cells were treated with different concentrations of BM (from 6 mg/ml to 4, 2 and 1 mg/ml) and incubated for 20 hours. Results were compared with data obtained from vehicle control treated cells. Two tailed t-test was used to evaluate the results. The obtained data showed that BM reduces the production of nitric oxide and prostaglandin E2. The substance suppresses production of pro-inflammatory cytokines including interleukin (IL)-6 and IL-1b.The results revealed that BM has anti-inflammatory activity and has a potential to suppress neuroinflammation. Brain macrophages-are the only cells that mediate brain inflammation. Extracellular neuromelanin can activate the CNS microglia inducing neuroinflammation and neurodegeneration. The water-soluble biotechnological melanin does not activate microglia – the resident brain macrophages.

Journal

Advances in Neuroimmune BiologyIOS Press

Published: Feb 25, 2020

References